BiBBInstruments AB Stock

Equities

BIBB

SE0010102095

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 18:00:00 2024-05-02 EDT 5-day change 1st Jan Change
4.6 SEK +0.22% Intraday chart for BiBBInstruments AB +0.66% +45.57%

Financials

Sales 2021 16K 1.48K 2.03K Sales 2022 - Capitalization 131M 12.11M 16.57M
Net income 2021 -10M -925K -1.27M Net income 2022 -11M -1.02M -1.39M EV / Sales 2021 9,916 x
Net cash position 2021 6.96M 644K 881K Net cash position 2022 13.45M 1.24M 1.7M EV / Sales 2022 -
P/E ratio 2021
-16.1 x
P/E ratio 2022
-10.8 x
Employees 3
Yield 2021 *
-
Yield 2022
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
BiBBInstruments Secures Patent for EndoDrill in India MT
BiBBInstruments AB Announces Successful Clinical Pilot Study with EndoDrill GI Published in Peer Reviewed Scientific Journal CI
BiBBInstruments Reports First Clinical Procedures in Sweden with Endoscopic Biopsy Instrument MT
Bibbinstruments AB First Clinical Tissue Acquisition Procedures with Endodrill® Gi At Karolinska University Hospital in Stockholm Have Been Successfully Performed CI
BiBBInstruments Wins Japanese Patent for Biopsy System MT
BiBBInstruments AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
BiBBInstruments AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BiBBInstruments Obtains European CE Certification for Endoscopic Biopsy Instrument MT
BiBBInstruments Reports First US Clinical Procedures with Core Needle Biopsy System MT
Bibbinstruments AB Announces First US Clinical Cases Successfully Conducted with Endodrill GI CI
BiBBInstruments AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BiBBInstruments Secures European Patent for Cancer Diagnostic Product MT
Bibb Receives Approval of Two Patents in Europe for Endodrill CI
BiBBInstruments AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news
1 day+0.22%
1 week+0.66%
Current month+0.88%
1 month+6.98%
3 months+50.33%
6 months+94.92%
Current year+45.57%
More quotes
1 week
4.31
Extreme 4.31
4.90
1 month
4.20
Extreme 4.2
4.98
Current year
2.60
Extreme 2.6
5.00
1 year
2.20
Extreme 2.2
5.00
3 years
1.90
Extreme 1.9
11.20
5 years
1.90
Extreme 1.9
11.20
10 years
1.90
Extreme 1.9
19.10
More quotes
Managers TitleAgeSince
Founder 50 12-12-31
Chief Executive Officer 57 13-08-31
Chief Tech/Sci/R&D Officer 38 19-10-31
Members of the board TitleAgeSince
Chairman 60 17-06-30
Director/Board Member 69 13-08-31
Chief Executive Officer 57 13-08-31
More insiders
Date Price Change Volume
24-05-03 4.6 +0.22% 13,758
24-05-02 4.59 +0.66% 3,576
24-04-30 4.56 +0.88% 11,689
24-04-29 4.52 -1.09% 7,903
24-04-26 4.57 +1.33% 20,363

End-of-day quote NORDIC GROWTH MARKET, May 02, 2024

More quotes
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio includes EndoDrill GI Upper for stomach biopsy, EndoDrill GI Lower for intestinal biopsy, EndoDrill GI Lung for lung biopsy, EndoDrill Therapy to pass displacements in different organs for placement of conductors, balloons and stents for treatment, EndoDrill Needle for breasts biopsy, as well as EndoDrill Model X for multiple areas and falls under independent research project. Products are distributed to hospitals with endoscopy specialists’ centers and surgical wards. The Company’s primary distribution focus is Scandinavian countries.
More about the company